- Home
- SYRS vs LCFY Comparison
SYRS vs LCFY Comparison
Compare SYRS & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRS
- LCFY
- Stock Information
- Founded
- SYRS 2011
- LCFY 2009
- Country
- SYRS United States
- LCFY Australia
- Employees
- SYRS N/A
- LCFY N/A
- Industry
- SYRS Biotechnology: Pharmaceutical Preparations
- LCFY
- Sector
- SYRS Health Care
- LCFY
- Exchange
- SYRS Nasdaq
- LCFY Nasdaq
- Market Cap
- SYRS 7.1M
- LCFY 7.3M
- IPO Year
- SYRS 2016
- LCFY 2022
- Fundamental
- Price
- SYRS $0.20
- LCFY $8.25
- Analyst Decision
- SYRS Hold
- LCFY
- Analyst Count
- SYRS 5
- LCFY 0
- Target Price
- SYRS $3.00
- LCFY N/A
- AVG Volume (30 Days)
- SYRS 3.2M
- LCFY 22.5K
- Earning Date
- SYRS 10-31-2024
- LCFY 11-12-2024
- Dividend Yield
- SYRS N/A
- LCFY N/A
- EPS Growth
- SYRS N/A
- LCFY N/A
- EPS
- SYRS N/A
- LCFY N/A
- Revenue
- SYRS $386,000.00
- LCFY $2,668,385.00
- Revenue This Year
- SYRS N/A
- LCFY N/A
- Revenue Next Year
- SYRS N/A
- LCFY N/A
- P/E Ratio
- SYRS N/A
- LCFY N/A
- Revenue Growth
- SYRS N/A
- LCFY N/A
- 52 Week Low
- SYRS $0.18
- LCFY $2.20
- 52 Week High
- SYRS $7.96
- LCFY $11.23
- Technical
- Relative Strength Index (RSI)
- SYRS 35.88
- LCFY 56.20
- Support Level
- SYRS $0.20
- LCFY $8.40
- Resistance Level
- SYRS $0.25
- LCFY $9.00
- Average True Range (ATR)
- SYRS 0.03
- LCFY 0.70
- MACD
- SYRS 0.02
- LCFY -0.03
- Stochastic Oscillator
- SYRS 5.19
- LCFY 39.44
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.